55513-0207
MVASI
Bevacizumab-awwb
INJECTION, SOLUTION
Intravenous
BEVACIZUMAB
400.0
mg/16mL

BEVACIZUMAB
400.0
mg/16mL
55513-0207-01
1 VIAL in 1 CARTON (55513-207-01) > 16 mL in 1 VIAL
June 1, 2018
Immunotherapy
Monoclonal Antibody
VEGFR
 
 
In Use